替加环素联合头孢哌酮-舒巴坦治疗广泛耐药鲍曼不动杆菌感染的医院获得性肺炎效果观察被引量：2

下载PDF

导出

摘要目的观察替加环素联合头孢哌酮-舒巴坦治疗广泛耐药鲍曼不动杆菌(PDR-Ab)感染的医院获得性肺炎(HAP)的效果。方法该院2015年1月至2016年12月确诊为PDR-Ab感染的HAP患者56例,按入院时间先后分为对照组与观察组各28例。对照组给予注射用头孢哌酮钠-舒巴坦钠,观察组在其基础上联合注射用替加环素治疗。结果观察组痊愈率(50.0%)、细菌清除率(67.9%)均高于对照组的21.4%和39.3%,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论替加环素联合头孢哌酮-舒巴坦治疗PDR-Ab感染的HAP效果优于单用头孢哌酮钠-舒巴坦钠,且不良反应少。

作者葛祥

机构地区浙江嘉兴市第二医院呼吸科

出处《中国乡村医药》 2017年第20期40-41,共2页

关键词头孢哌酮-舒巴坦替加环素鲍曼不动杆菌广泛耐药医院获得性肺炎

分类号 R563.1 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献7

1俞云松.多药耐药鲍曼不动杆菌——21世纪革兰阴性菌的“MRSA”[J].中华临床感染病杂志,2009,2(2):65-68. 被引量：93
2周洋,黄河,张家洪.替加环素联合头孢哌酮舒巴坦治疗多重耐药鲍曼不动杆菌肺炎的疗效观察[J].实用医学杂志,2015,31(5):816-818. 被引量：65
3王旭东.医院获得性肺炎[J].中国临床医生杂志,2005,33(1):15-16. 被引量：14
4孙谦,周宏伟,胡燕燕,陈功祥.多重耐药鲍曼不动杆菌对替加环素耐药状况分析[J].中华检验医学杂志,2011,34(4):358-362. 被引量：29
5张朝晖,钟建华,张蓉,瞿星光,龚勋,周刚,曾超,李灵丰,姚玲.头孢哌酮-舒巴坦治疗泛耐药鲍曼不动杆菌医院获得性肺炎36例[J].中国感染与化疗杂志,2012,12(6):416-418. 被引量：21
6高金丹,方强,苏群.替加环素治疗多重或泛耐药鲍曼不动杆菌引起的重症肺炎的疗效评价[J].中国抗生素杂志,2015,40(8):621-625. 被引量：69
7秦又发,吴雷,朱永坤,张扬.替加环素联合头孢哌酮-舒巴坦治疗广泛耐药鲍曼不动杆菌医院获得性肺炎临床疗效观察[J].中国感染与化疗杂志,2015,15(5):430-433. 被引量：38

二级参考文献68

1Yang SC,Chang WJ,Chang YH,et al.Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan.Eur J Clin Microbiol Infect Dis,2010,29:601-604.
2Mezzatesta ML,Trovato G,Gona F,et al.In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy.Ann Clin Microbiol Antimicrob,2008,7:1-7.
3Livermore DM.Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:our worst nightmare? Clin Infect Dis,2002,34:634-640.
4Somily AM.Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli.Saudi Med J,2010,31:507-511.
5Liu JW,Wang LS,Cheng YJ,et al.In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.Int J Antimicrob Agents,2008,32:188-191.
6Dizbay M,Ahuncekic A,Sezer BE,et al.Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.Int J Antimicrob Agents,2008,32:29-32.
7Navon-Venezia S,Leavitt A,Carmeli Y.High tigecycllne resistance in multidrug-resistant Acinetobacter baumannii.J Antimicrob Chemother,2007,59:772-774.
8Capone A,D'Arezzo S,Visca P,et al.In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.J Antimicrob Chemother,2008,62:422-423.
9Clinical and Laboratory Standards Institute.Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically.20th ed.Approved standard M7-A8.Wayne:CLSI,2010.
10Tenover FC,Arbeit RD,Goering RV,et al.Interpreting Chromosomal DNA Restriction Patterns Produced by Pulsed-Field Gel Electrophoresis:Criteria for Bacterial Strain Typing.J Clin Microbiol,1995,33:2233-2239.